Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Enabling Genomic Technologies

Duncan Ayers's Biography



Duncan Ayers, Post Doctoral Researcher, University of Malta / University of Manchester

Dr. Duncan Ayers has completed his PhD in Translational Medicine from The University of Manchester (UK) in 2011 and is currently continuing his post-doctoral research at The University of Malta. Dr. Ayers also holds a MSc degree in Immunology and Immunogenetics from the University of Manchester and is currently a Research Associate with the Faculty of Medicine & Human Health Sciences at the University of Manchester. During his doctoral studies, Dr. Ayers also spent a 17-month attachment with the Vandesompele research group at the Center for Medical Genetics Ghent (Ghent University, Ghent, Belgium). Dr. Ayers’ research focuses mainly on non-coding RNA biomarker discovery and therapeutic applications for paediatric cancers such as neuroblastoma. Other research interests include the influences of gene, micro RNA (miRNA) and other non-coding RNA expression profiles in the development of human disease conditions, high throughput semi-/quantitative gene (or miRNA, lncRNA, etc.) analytical techniques such as RT-qPCR, microarray platform utilization and the development of nanoparticle – based drug delivery systems for RNA interference-based therapeutics in cancer. Dr. Ayers’ research has been published / presented in over 35 reputed peer-reviewed journal papers and international meetings, together with contributing to four book publications. In addition, he is also editor for the Journal of Cancer Research and Treatment (USA).

Duncan Ayers Image

Functional evaluation for the utilisation of recognised oncogenic miRNAs as neuroblastoma chemoresistance biomarkers

Thursday, 11 September 2014 at 15:45

Add to Calendar ▼2014-09-11 15:45:002014-09-11 16:45:00Europe/LondonFunctional evaluation for the utilisation of recognised oncogenic miRNAs as neuroblastoma chemoresistance biomarkersSELECTBIOenquiries@selectbiosciences.com

This project focuses on exploring possible correlations between dys-regulated expression of miRNAs (recognised to be oncogenic in multiple cancer models) and neuroblastoma chemoresistance properties within representative cell lines.


Add to Calendar ▼2014-09-11 00:00:002014-09-12 00:00:00Europe/LondonEnabling Genomic TechnologiesSELECTBIOenquiries@selectbiosciences.com